---
title: "Federated Learning and In-House Dashboards for Data Quality Assurance in Multi‑Center Oncology Data"
id: "medrxiv-14-data-auditing-and-quality-assurance-in-a-federated-learning-consortium-getting"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-14-data-auditing-and-quality-assurance-in-a-federated-learning-consortium-getting"
content_type: "clinical_feed_article"
specialty: "Oncology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.08.26361592v1?rss=1"
published_at: "2026-09-17T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Federated Learning and In-House Dashboards for Data Quality Assurance in Multi‑Center Oncology Data
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-14-data-auditing-and-quality-assurance-in-a-federated-learning-consortium-getting
- **Specialty:** [Oncology](https://medichelpline.com/clinical-feed/oncology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.08.26361592v1?rss=1)
- **Published At:** 2026-09-17T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The study evaluates complementary approaches to **data quality** inspection in a federated learning (FL) consortium using breast cancer electronic health record (EHR) data from Centre Léon Bérard. - Two dashboards were implemented: an **in‑house dashboard** for detailed, individual‑level quality assessment and a **federated dashboard** for cross‑institutional pattern detection and ecosystem‑level oversight. - The authors adapted an established EHR data quality control framework for reuse in both dashboard contexts to make comparisons meaningful and repeatable. - Artificial inconsistencies were deliberately injected into distributed datasets mirroring the in‑house source to test each dashboard’s detection capability. - The in‑house dashboard detected individual‑level inconsistencies with higher granularity and reliability, enabling local validation and exhaustive checks. - The federated dashboard identified inter‑clinic trends and systemic patterns that single‑institution tools cannot reveal, supporting scalable, collaborative monitoring across institutions. - Trade‑offs were identified: **scalability** and collaborative oversight favored federated tools, while **thoroughness** and local validation favored in‑house tools. - The authors conclude that a combined model — integrating federated and in‑house inspection — provides a better balance for multi‑institutional research, addressing both institution‑specific and consortium‑level needs. - Data used in the study are not public; access requests are to be directed to the named contact. The study followed institutional privacy and GDPR procedures, including date shifting and minimum consent thresholds.
## Clinical Analysis & Structured Key Points
Data Auditing and Quality Assurance in a Federated Learning Consortium; Getting the Best of Both Worlds from Cross-Institutional and In-House Data Quality Inspection | medRxiv Skip to main content Data Auditing and Quality Assurance in a Federated Learning Consortium; Getting the Best of Both Worlds from Cross-Institutional and In-House Data Quality Inspection View ORCID Profile Joshi Hogenboom , Natacha Perez , Quentin Filori , Alric Sans , View ORCID Profile Aiara Lobo Gomes , View ORCID Profile Andre Dekker , View ORCID Profile Winette van der Graaf , View ORCID Profile Olga Husson , View ORCID Profile Hugo Crochet , View ORCID Profile Leonard Wee , View ORCID Profile Varsha Gouthamchand doi: https://doi.org/10.64898/2026.09.08.26361592 Joshi Hogenboom 1 Maastricht University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Joshi Hogenboom For correspondence: joshi.hogenboom{at}maastrichtuniversity.nl Natacha Perez 2 Centre Léon Bérard; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Quentin Filori 2 Centre Léon Bérard; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Alric Sans 2 Centre Léon Bérard; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Aiara Lobo Gomes 3 RWTH Aachen University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Aiara Lobo Gomes Andre Dekker 4 Maastro Clinic; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Andre Dekker Winette van der Graaf 5 Netherlands Cancer Institute Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Winette van der Graaf Olga Husson 5 Netherlands Cancer Institute Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Olga Husson Hugo Crochet 2 Centre Léon Bérard; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Hugo Crochet Leonard Wee 1 Maastricht University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Leonard Wee Varsha Gouthamchand 1 Maastricht University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Varsha Gouthamchand Abstract Info/History Metrics Supplementary material Data/Code Preview PDF Abstract Introduction: Rare and heterogeneous disease research increasingly relies on privacy-enhancing technologies such as federated learning (FL) to enable cross-institutional collaboration across fragmented datasets. However, data quality assurance in FL can be limited, as individual-level data may not be directly accessible. While schema-dependent inspection offers a partial solution, it requires standardised schemas or resource-intensive frameworks, hindering scalability and collaboration. To address these challenges, we implemented two complementary dashboards and evaluated their interplay. Methodology: We adapted a recognised data quality control framework for re-use of electronic health record (EHR) data using breast cancer records from Centre Leon Berard into two dashboards: (1) an in-house dashboard for intra-clinic quality assessment, and (2) a federated dashboard for inter-clinic quality assessment. Artificial inconsistencies were introduced into distributed datasets mirroring the in-house source to evaluate detection capabilities. Results: The in-house dashboard provided granularity and reliability, pinpointing individual-level inconsistencies, while the federated dashboard enabled cross-institutional pattern detection - trade-offs inherent to their designs. The federated system revealed ecosystem-wide trends inaccessible to single-institution tools, whereas the in-house dashboard provided local validation and thoroughness. Discussion: Our findings confirm a complementary relationship: FL dashboards provide scalable, collaborative oversight but may require additional quality checks, while in-house tools ensure thoroughness at the cost of scalability. A combined model seemingly offers the optimal balance, accommodating both institution-specific needs and collaborative research requirements in evolving, multi-institutional ecosystems. Competing Interest Statement A.L.A.J. Dekker is employed by Medical Data Works B.V., holds stock or ownership interests in Medical Data Works B.V., and has received travel, accommodations, and expense support from Medical Data Works B.V. W.T.A. van der Graaf has receivedinstitutional research funding from Lilly. All other authors have declared no conflicts of interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The study used a subset of breast cancer patients recorded in the institutional breast cancer database, restricted to patients with an information level of at least 5 - a threshold corresponding to explicit patient consent for the use of their health data in research. Secondary use of these healthcare data was conducted in accordance with the French MR004 reference methodology. The project underwent review by the data protection office of CLB (Centre Leon Berard), received a General Data Protection Regulation (GDPR) certificate, and was registered in CLB's GDPR registry. To limit re-identification risks inherent to routine clinical data reuse, we applied an internal privacy transformation involving uniform date-shifting, thereby maintaining internal temporal relationships between events. All data processing procedures are documented in the information notice available on the Unicancer transparency portal, for review by individuals included in the dataset. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability The data analyzed in this study is subject to the following licenses/restrictions: The datasets used are not publically available. Requests to access these datasets should be directed to Hugo Crochet. https://github.com/STRONGAYA/federated-data-management-portal Funder Information Declared European Union Horizon 2020 research and innovation programme , 101057482 Netherlands Organization for Scientific Research ZonMw, The Dutch Organisation for knowledge and innovation in health, healthcare and well-being, https://ror.org/01yaj9a77 Stiching Hanarth fonds Velux Stiftung, https://ror.org/00kgf1c95 Innovative Medicines Initiative, https://ror.org/019af4n30 Digital Oncology Network for Europe European Regional Development Fund Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license . Back to top Previous Posted September 17, 2026. Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Data Auditing and Quality Assurance in a Federated Learning Consortium; Getting the Best of Both Worlds from Cross-Institutional and In-House Data Quality Inspection Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Data Auditing and Quality Assurance in a Federated Learning Consortium; Getting the Best of Both Worlds from Cross-Institutional and In-House Data Quality Inspection Joshi Hogenboom , Natacha Perez , Quentin Filori , Alric Sans , Aiara Lobo Gomes , Andre Dekker , Winette van der Graaf , Olga Husson , Hugo Crochet , Leonard Wee , Varsha Gouthamchand medRxiv 2026.09.08.26361592; doi: https://doi.org/10.64898/2026.09.08.26361592 Share This Article: Copy Citation Tools Data Auditing and Quality Assurance in a Federated Learning Consortium; Getting the Best of Both Worlds from Cross-Institutional and In-House Data Quality Inspection Joshi Hogenboom , Natacha Perez , Quentin Filori , Alric Sans , Aiara Lobo Gomes , Andre Dekker , Winette van der Graaf , Olga Husson , Hugo Crochet , Leonard Wee , Varsha Gouthamchand medRxiv 2026.09.08.26361592; doi: https://doi.org/10.64898/2026.09.08.26361592 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Addiction Medicine (617) Allergy and Immunology (902) Anesthesia (334) Cardiovascular Medicine (4819) Dentistry and Oral Medicine (479) Dermatology (415) Emergency Medicine (650) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1630) Epidemiology (15955) Forensic Medicine (33) Gastroenterology (1203) Genetic and Genomic Medicine (7053) Geriatric Medicine (733) Health Economics (1065) Health Informatics (5052) Health Policy (1435) Health Systems and Quality Improvement (1768) Hematology (586) HIV/AIDS (1346) Infectious Diseases (except HIV/AIDS) (16298) Intensive Care and Critical Care Medicine (1173) Medical Education (669) Medical Ethics (155) Nephrology (725) Neurology (7283) Nursing (368) Nutrition (1082) Obstetrics and Gynecology (1241) Occupational and Environmental Health (1005) Oncology (3611) Ophthalmology (1054) Orthopedics (398) Otolaryngology (457) Pain Medicine (471) Palliative Medicine (139) Pathology (709) Pediatrics (1801) Pharmacology and Therapeutics (737) Primary Care Research (767) Psychiatry and Clinical Psychology (5906) Public and Global Health (9763) Radiology and Imaging (2429) Rehabilitation Medicine and Physical Therapy (1454) Respiratory Medicine (1249) Rheumatology (642) Sexual and Reproductive Health (772) Sports Medicine (578) Surgery (780) Toxicology (107) Transplantation (305) Urology (291)
## Related Clinical Research

- [Inflammatory Biomarkers and Risk of Postmenopausal ER-Positive Breast Cancer](https://medichelpline.com/clinical-feed/british-journal-of-cancer-0-inflammatory-biomarkers-and-risk-of-postmenopausal-oestrogen-receptor-positive.md)
- [Educating Patients on ‘Asian Glow’ and Alcohol Risks in East Asian Populations](https://medichelpline.com/clinical-feed/stat-news-0-opinion-doctors-should-educate-patients-about-asian-glow-and-drinking-risks.md)
- [Sellas Phase 3 REGAL trial for galinpepimut-S faces delays and likely negative outcome in AML](https://medichelpline.com/clinical-feed/stat-news-1-stat-a-sellas-immunotherapy-study-long-delayed-will-end-in-failure.md)
- [Healthy lifestyle and pan-cancer risk: UK Biobank prospective analysis](https://medichelpline.com/clinical-feed/british-journal-of-cancer-2-healthy-lifestyle-and-cancer-risk-a-pan-cancer-analysis-in-the-uk-biobank.md)
- [Daraxonrasib shows activity in RAS‑mutant NSCLC after FDA approval in pancreatic cancer](https://medichelpline.com/clinical-feed/medical-news-today-0-pancreatic-cancer-drug-may-also-help-fight-treatment-resistant-lung-cancer.md)

## Navigation
- [← Back to Oncology Feed](https://medichelpline.com/clinical-feed/oncology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.